Executive Forum

Cellink Life Sciences completes Nanoscribe acquisition

June 1, 2021

Nanoscribe specializes in 3D bioprinting based on two-photon polymerization technology.

On May 31, 2021, bioconvergence company Cellink Life Sciences (Gothenburg, Sweden) finalized its acquisition of Nanoscribe (Karlsruhe, Germany), a company focusing on development of high-precision 3D printers based on two-photon polymerization (2PP) technology.

The combination of the two companies’ technologies enables Cellink to offer 2PP products for several markets, such as bioprinting, microfluidics, micro-optics, micromechanics, biomedical engineering, and integrated photonics technologies, explains Erik Gatenholm, CEO of Cellink. One example, he says, is the sample preparation steps for single-cell genomics applications.

Source: Cellink Life Sciences press release

Continue Reading

Is your Quantum 2.0 solution stable enough?

Optical design software: From nano to system scale

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025

Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025

To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025

In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025

In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...